127 related articles for article (PubMed ID: 8020528)
1. Study on the absorption of vinpocetine and apovincaminic acid.
Pudleiner P; Vereczkey L
Eur J Drug Metab Pharmacokinet; 1993; 18(4):317-21. PubMed ID: 8020528
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of apovincaminic acid in dogs.
Vereczkey L; Pudleiner P
Pol J Pharmacol Pharm; 1987; 39(2):161-5. PubMed ID: 3432163
[TBL] [Abstract][Full Text] [Related]
3. Effect of age on the pharmacokinetics of vinpocetine (Cavinton) and apovincaminic acid.
Miskolczi P; Vereczkey L; Szalay L; Göndöc C
Eur J Clin Pharmacol; 1987; 33(2):185-9. PubMed ID: 3691609
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans.
Miskolczi P; Kozma K; Polgár M; Vereczkey L
Eur J Drug Metab Pharmacokinet; 1990; 15(1):1-5. PubMed ID: 2384112
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and metabolic studies of vinpocetine on dogs. II. Metabolism.
Szeleczky G; Vereczkey L
Pol J Pharmacol Pharm; 1986; 38(3):269-75. PubMed ID: 3774625
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole does not change the oral bioavailability or pharmacokinetics of vinpocetine in rats.
Sozański T; Magdalan J; Trocha M; Szumny A; Merwid-Ląd A; Słupski W; Karaźniewicz-Łada M; Kiełbowicz G; Ksiądzyna D; Szeląg A
Pharmacol Rep; 2011; 63(5):1258-63. PubMed ID: 22180371
[TBL] [Abstract][Full Text] [Related]
7. Kinetic metabolism of vinpocetine in the rat.
Vereczkey L; Szentirmay Z; Szporny L
Arzneimittelforschung; 1979; 29(6):953-6. PubMed ID: 582790
[TBL] [Abstract][Full Text] [Related]
8. Vinpocetine pharmacokinetics in elderly subjects.
Grandt R; Beitinger H; Schaltenbrand R; Braun W
Arzneimittelforschung; 1989 Dec; 39(12):1599-602. PubMed ID: 2624613
[TBL] [Abstract][Full Text] [Related]
9. Determination of apovincaminic acid in serum by means of high-performance liquid chromatography.
Kraus G; Schulz HU; Lohmann A
J Chromatogr; 1992 Jan; 573(2):323-7. PubMed ID: 1601968
[TBL] [Abstract][Full Text] [Related]
10. Determination of apovincaminic acid in human plasma by high-performance liquid chromatography.
Maya MT; Pais JP; Araújo HM; Morais JA
J Pharm Biomed Anal; 1996 Mar; 14(5):617-22. PubMed ID: 8738192
[TBL] [Abstract][Full Text] [Related]
11. [Human positron emission tomography with oral 11C-vinpocetine].
Vas A; Christer H; Sóvágó J; Johan S; Cselényi Z; Kiss B; Kárpáti E; Lars F; Gulyás B
Orv Hetil; 2003 Nov; 144(46):2271-6. PubMed ID: 14702922
[TBL] [Abstract][Full Text] [Related]
12. Determination of apovincaminic acid in biological samples by high-performance liquid chromatography.
Kozma M; Pudleiner P; Vereczkey L
J Chromatogr; 1982 May; 241(1):177-82. PubMed ID: 7107794
[TBL] [Abstract][Full Text] [Related]
13. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
Imamoto T; Tanabe M; Shimamoto N; Kawazoe K; Hirata M
Arzneimittelforschung; 1984; 34(2):161-9. PubMed ID: 6539108
[TBL] [Abstract][Full Text] [Related]
14. Determination of apovincaminic acid in human plasma by high-performance liquid chromatography using solid-phase extraction and ultraviolet detection.
Chen J; Cai J; Tao W; Mei N; Cao S; Jiang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):201-6. PubMed ID: 16321580
[TBL] [Abstract][Full Text] [Related]
15. Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine.
Gulyás B; Halldin C; Sóvágó J; Sandell J; Cselényi Z; Vas A; Kiss B; Kárpáti E; Farde L
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1031-8. PubMed ID: 12173017
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the possible influence of the absorption of vinpocetine with concomitant application of magnesium-aluminium-hydroxide gel.
Lohmann A; Grobara P; Dingler E
Arzneimittelforschung; 1991 Nov; 41(11):1164-7. PubMed ID: 1810262
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics and disposition of vinpocetine in rats].
Yao JH; Su CY; Chu XY
Yao Xue Xue Bao; 1994; 29(2):81-5. PubMed ID: 8042515
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and comparative bioavailability of two vinpocetine tablet formulations in healthy volunteers by using the metabolite apovincaminic acid as pharmacokinetic parameter.
Vlase L; Bodiu B; Leucuta SE
Arzneimittelforschung; 2005; 55(11):664-8. PubMed ID: 16366040
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of vinpocetine and apovincaminic acid in patients with impaired renal function.
Miskolczi P; Vereczkey L; Szalay L; Göndöcs CS
Eur J Drug Metab Pharmacokinet; 1984; 9(2):169-75. PubMed ID: 6745306
[TBL] [Abstract][Full Text] [Related]
20. Lack of pharmacokinetic interaction between vinpocetine and oxazepam.
Storm G; Oosterhuis B; Sollie FA; Visscher HW; Sommer W; Beitinger H; Jonkman JH
Br J Clin Pharmacol; 1994 Aug; 38(2):143-6. PubMed ID: 7981015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
